The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence following a prostatectomy. The first p...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival...

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney fail...

Breast cancer vaccine results promising, moves to next stage in clinical trials A vaccine to prevent breast cancer is showing good results, and moving into the ne...

A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromusc...

The patient experience in healthcare is often the focal point of interaction between patients and their clinicians. It is frequently based on a relationship built ov...

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical resear...

A four-year-old London start-up backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The an...

Ever since the gene responsible for cystic fibrosis was discovered 25 years ago, scientists have envisaged gene therapies to correct the underlying genetic defect. ...

CVS Health has said it will beef up its clinical trials operations, improving its ability to recruit patients from a broad demographic spectrum, via an agreement wit...